Eisler Capital (Us) LLC Abbott Laboratories Put Options Transaction History

Eisler Capital (Us) LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $680,476 - $803,284	6,800 Added 4.95%	144,100 $16.4 Billion
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $6.23 Million - $6.95 Million	61,800 Added 81.85%	137,300 $14.3 Billion
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $930,920 - $1.03 Million	-8,500 Reduced 10.12%	75,500 $8.58 Billion
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $5.95 Million - $7.29 Million	-66,000 Reduced 44.0%	84,000 $9.25 Billion
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $7.49 Million - $8.99 Million	78,400 Added 109.5%	150,000 $14.5 Billion
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $7.22 Million - $8.04 Million	71,600 New	71,600 $7.81 Billion

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $202B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Eisler Capital (Us) LLC, based on Form 13F filings with the SEC.

Stay updated on Eisler Capital (Us) LLC with notifications on news.